Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R6S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,010
Award facts
- Contract value 100% obligated
- $33,009.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,009.52 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections on a firm fixed-price basis. The award, effective January 30, 2026, with an ultimate completion date of February 2, 2026, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC vehicle enables the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The award demonstrates the contractor's capability to meet federal procurement requirements through open competition and supports the Defense Health Agency and other government healthcare systems' pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DR26F9R6S?
SPE2DR26F9R6S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9R6S worth?
The government has obligated $33,010 on SPE2DR26F9R6S.
Is contract SPE2DR26F9R6S an order under another contract?
Yes. SPE2DR26F9R6S is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R6S competed?
The extent of competition for SPE2DR26F9R6S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award